Erik R Vandendries
Overview
Explore the profile of Erik R Vandendries including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kantarjian H, DeAngelo D, Advani A, Stelljes M, Kebriaei P, Cassaday R, et al.
Lancet Haematol
. 2017 Jul;
4(8):e387-e398.
PMID: 28687420
Background: The INO-VATE study demonstrated efficacy and safety of inotuzumab ozogamicin versus standard care in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia. Here, we report the frequency of,...
2.
Wagner-Johnston N, Goy A, Rodriguez M, Ehmann W, Hamlin P, Radford J, et al.
Leuk Lymphoma
. 2015 Feb;
56(10):2863-9.
PMID: 25707288
This study evaluated the safety and efficacy of inotuzumab ozogamicin (INO), a targeted humanized anti-CD22 antibody conjugated to calicheamicin, plus rituximab (R-INO) every 3 weeks, up to six cycles, followed...
3.
Vandendries E, Hamilton J, Coughlin S, Furie B, Furie B
Proc Natl Acad Sci U S A
. 2006 Dec;
104(1):288-92.
PMID: 17190826
Thrombin, a central mediator of hemostasis and thrombosis, converts fibrinogen to fibrin and is a potent platelet activator. Activated platelets provide a surface for assembly of the tenase and prothrombinase...
4.
Vandendries E, Drews R
Crit Care Clin
. 2006 May;
22(2):347-55, viii.
PMID: 16678004
Hematologic dysfunction, including thrombocytopenia, anemia, neutropenia, thromboses, and coagulopathy, occur commonly during critical illnesses. A major challenge is to identify drug-induced causes of hematologic dysfunction. Given the wide variety of...
5.
Vandendries E, Furie B, Furie B
Thromb Haemost
. 2004 Sep;
92(3):459-66.
PMID: 15351841
P-selectin and PSGL-1 are cell adhesion molecules, regulating the initial interactions between leukocytes and the blood vessel wall as well as between activated platelets and leukocytes. P-selectin is expressed on...